Calliditas Therapeutics AB (CALT)
40.00
0.00 (0.00%)
USD |
NASDAQ |
Sep 27, 16:00
Calliditas Therapeutics Gross Profit Margin (Quarterly): 90.45% for June 30, 2024
Gross Profit Margin (Quarterly) Chart
Historical Gross Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2024 | 90.45% |
| March 31, 2024 | 95.26% |
| December 31, 2023 | 95.06% |
| September 30, 2023 | 94.94% |
| June 30, 2023 | 94.72% |
| Date | Value |
|---|---|
| March 31, 2023 | 95.28% |
| December 31, 2022 | 98.16% |
| September 30, 2022 | 98.34% |
| June 30, 2022 | 96.28% |
| March 31, 2022 | 98.77% |
Gross Profit Margin Definition
Gross Profit Margin is calculated using Gross Profit/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into gross profit and doing this by keeping cost of goods sold low. An analyst looking at gross profit margin might look for a higher gross profit margin relative to other comparable companies as well as a gross profit margin that is growing.
Gross Profit Margin (Quarterly) Range, Past 5 Years
90.45%
Minimum
Jun 2024
98.77%
Maximum
Mar 2022
95.73%
Average
95.27%
Median
Gross Profit Margin (Quarterly) Benchmarks
Gross Profit Margin (Quarterly) Related Metrics
| Return on Equity | -170.7% |
| Return on Assets | -28.00% |
| Return on Invested Capital | -41.42% |
| Profit Margin (Quarterly) | -8.48% |
| Operating Margin (Quarterly) | -5.63% |
| Return on Net Operating Assets | -28.89% |